跳至主要内容
临床试验/CTRI/2025/04/085758
CTRI/2025/04/085758尚未招募2 期

An Etiopathological Study of Urticaria (Sheetpitta) and Therapeutic trial of Panchnimbadi Churna

Dr Sunil Kumar1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年10月5日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Sign and symptoms will be assessed before and after treatment. i.e- Kandu, Mandalakar, Utsedna, Toda, Daha, Sotha etc

研究概览

简要总结

THIS STYDY IS SINGLE ARM TRIAL TO KNOW THE EFFECTNESS OF PANCHNIMBADI CHURN IN URTICARIA (SHEETPITTA) THAT WILL BE CONDUCTED IN GOVERMENT AYURVEDIC COLLEGE AND HOSPITAL PATNA , IN THE DEPARTMENT OF ROG NIDIAN EVAM VIKRITI VIGYAN IN THE GROUP 30 PATIENTS AFTER THE 15 DAYS INTERVENTIONS, FOLLOW UP IS DONE AT EVERY 15 DAYS FOR THE ENTIRE DURATION OF THE STUDY, i,e  60 DAYS.

研究设计

研究类型
Interventional
分配方式
Adaptive randomization, such as minimization
盲法
Open Label

入排标准

年龄范围
12.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • The sign and symptoms of Urticaria (Sheetpitta) based on both ayurvedic as well as modern view.

排除标准

  • Patients below 12 years and above 60 years.
  • Immunocompromised patients example HIV.
  • Patients is unwillings.
  • Patients with complicated associated symptoms example severly ill liver cirrhosis adenocarcinoma.

结局指标

主要结局

Sign and symptoms will be assessed before and after treatment. i.e- Kandu, Mandalakar, Utsedna, Toda, Daha, Sotha etc

时间窗: Total 30 Patients | Duration- 60 Days

次要结局

  • CBC & LFT test will be done in patients before & after treatment(Total- 30 Patients)

研究者

发起方
Dr Sunil Kumar
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验